Mar 13, 2026
Ro Khanna- Amount
- Receipt pending ingestion
- Filed
- Apr 7, 2026
Congress ticker disclosure profile
As of August 1 at 5:10 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference NGG. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
26
Member filers
12
Disclosed ranges
$514K
Most active member desks
14 buys vs 12 sells
Democrat · House · CA-17.0
Republican · House · 3.0
Republican · House · US
Democrat · House · NY-10.0
Republican · Senate · ND
Democrat · House · MA-5.0
Republican · House · MI-9.0
Republican · House · TX-3.0
Democrat · House · OR-4.0
Democrat · Senate · MD
Latest trade Mar 13, 2026
Mar 13, 2026
Ro KhannaSep 23, 2025
Valerie HoyleJul 10, 2025
Lisa McclainJun 24, 2025
Lisa McclainOct 29, 2024
Valerie HoyleMar 8, 2024
Ro KhannaJul 10, 2023
Daniel GoldmanJun 9, 2023
Ro KhannaApr 14, 2023
Ro KhannaFeb 27, 2023
Daniel GoldmanNov 5, 2020
Katherine M. ClarkOct 22, 2020
Katherine M. ClarkMar 18, 2020
Greg GianforteMar 25, 2019
Nicholas Van TaylorMar 25, 2019
Nicholas Van TaylorSep 21, 2017
John HoevenMar 2, 2017
John HoevenOct 10, 2016
Thomas MacarthurSep 20, 2016
Thomas MacarthurAug 5, 2016
Thomas MacarthurFeb 22, 2016
Thomas MacarthurDec 4, 2015
Michael T. McCaulNov 17, 2014
Benjamin L. CardinMay 20, 2014
Robert P Corker JrMar 3, 2014
Robert P Corker JrJan 8, 2014
Robert P Corker Jr| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Mar 13, 2026 | Ro Khanna | Buy | Receipt pending ingestion | Apr 7, 2026 | Open card |
| Sep 23, 2025 | Valerie Hoyle | Sell | $1,001 to $15,000 | Oct 10, 2025 | Open card |
| Jul 10, 2025 | Lisa Mcclain | Sell | $1,001 to $15,000 | Aug 13, 2025 | Open card |
| Jun 24, 2025 | Lisa Mcclain | Buy | $1,001 to $15,000 | Aug 13, 2025 | Open card |
| Oct 29, 2024 | Valerie Hoyle | Buy | $1,001 to $15,000 | Sep 12, 2025 | Open card |
| Mar 8, 2024 | Ro Khanna | Buy | Receipt pending ingestion | Apr 5, 2024 | Open card |
| Jul 10, 2023 | Daniel Goldman | Sell | $50,001 to $100,000 | Aug 13, 2023 | Open card |
| Jun 9, 2023 | Ro Khanna | Buy | Receipt pending ingestion | Jul 11, 2023 | Open card |
| Apr 14, 2023 | Ro Khanna | Buy | Receipt pending ingestion | May 8, 2023 | Open card |
| Feb 27, 2023 | Daniel Goldman | Buy | $1,001 to $15,000 | Mar 20, 2023 | Open card |
| Nov 5, 2020 | Katherine M. Clark | Sell | Receipt pending ingestion | Dec 28, 2020 | Open card |
| Oct 22, 2020 | Katherine M. Clark | Buy | Receipt pending ingestion | Dec 3, 2020 | Open card |
| Mar 18, 2020 | Greg Gianforte | Buy | $1,001 to $15,000 | Apr 7, 2020 | Open card |
| Mar 25, 2019 | Nicholas Van Taylor | Sell | $1,001 to $15,000 | Apr 15, 2019 | Open card |
| Mar 25, 2019 | Nicholas Van Taylor | Sell | $15,001 to $50,000 | Apr 15, 2019 | Open card |
| Sep 21, 2017 | John Hoeven | Sell | $100,001 to $250,000 | Sep 27, 2017 | Open card |
| Mar 2, 2017 | John Hoeven | Buy | $100,001 to $250,000 | Mar 6, 2017 | Open card |
| Oct 10, 2016 | Thomas Macarthur | Sell | Receipt pending ingestion | Nov 7, 2016 | Open card |
| Sep 20, 2016 | Thomas Macarthur | Buy | Receipt pending ingestion | Nov 7, 2016 | Open card |
| Aug 5, 2016 | Thomas Macarthur | Sell | Receipt pending ingestion | Sep 10, 2016 | Open card |
| Feb 22, 2016 | Thomas Macarthur | Buy | Receipt pending ingestion | Mar 3, 2016 | Open card |
| Dec 4, 2015 | Michael T. McCaul | Sell | Receipt pending ingestion | Feb 3, 2016 | Open card |
| Nov 17, 2014 | Benjamin L. Cardin | Sell | Receipt pending ingestion | Nov 29, 2014 | Receipt pending ingestion |
| May 20, 2014 | Robert P Corker Jr | Sell | Receipt pending ingestion | Jun 10, 2014 | Receipt pending ingestion |
| Mar 3, 2014 | Robert P Corker Jr | Buy | Receipt pending ingestion | Jun 10, 2014 | Receipt pending ingestion |
| Jan 8, 2014 | Robert P Corker Jr | Buy | Receipt pending ingestion | Jun 10, 2014 | Receipt pending ingestion |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 11 of 26 filed rows include disclosed amount ranges (42%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.